Fairvalue-Calculator Fairvalue-Calculator
EN DE

Landfar Bio-medicine Co (000504) Fair Value & Analysis

Healthcare · CN · Market cap 2.7B CNY

Price¥7.91
Fair Value¥1.92
Upside-75.7%
Quality81/100
Evidence: Medium Range ¥1.44 – ¥2.40

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Landfar Bio-medicine Co (000504) currently trades at ¥7.91, while our model-based Fair Value estimate is ¥1.92 — implying the stock looks roughly 75.7% overvalued today. We read business quality at 81/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Landfar Bio-medicine Co., Ltd operates as a biomedical technology company. It operates in two segments, Biomedicine, and Energy Saving and Environmental Protection. The Biomedicine segment engages in the provision of stem cell, immune cell storage and technical services, and medical device trade. The Energy Saving and Environmental Protection segment is involved in the external energy management contract energy management business; build-transfer business and sales of related products; and sewage treatment business. The company was founded in 1991 and is based in Changsha, China.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Landfar Bio-medicine Co (000504) undervalued?
As of Jun 25, 2026, our model estimates a fair value of ¥1.92 versus a price of ¥7.91 — about −76% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 000504?
Our 21-model fair value for Landfar Bio-medicine Co is ¥1.92 (as of Jun 25, 2026), built from audited fundamentals. The current price is ¥7.91.
What is the quality score of 000504?
Landfar Bio-medicine Co has a Quality Score of 81/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.